Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042071
Filing Date
2021-08-12
Accepted
2021-08-12 16:39:28
Documents
49
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_citiuspharma.htm   iXBRL 10-Q 611296
2 CERTIFICATION f10q0621ex31-1_citiuspharma.htm EX-31.1 10450
3 CERTIFICATION f10q0621ex31-2_citiuspharma.htm EX-31.2 10437
4 CERTIFICATION f10q0621ex32-1_citiuspharma.htm EX-32.1 6749
  Complete submission text file 0001213900-21-042071.txt   3659894

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20210630.xsd EX-101.SCH 47428
6 XBRL CALCULATION FILE ctxr-20210630_cal.xml EX-101.CAL 31808
7 XBRL DEFINITION FILE ctxr-20210630_def.xml EX-101.DEF 187233
8 XBRL LABEL FILE ctxr-20210630_lab.xml EX-101.LAB 392609
9 XBRL PRESENTATION FILE ctxr-20210630_pre.xml EX-101.PRE 197105
10 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_citiuspharma_htm.xml XML 371225
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 211168236
SIC: 2834 Pharmaceutical Preparations